Effect of therapy on residual beta cell function in type-1 diabetes mellitus
- Conditions
- Type 1 diabetes mellitusNutritional, Metabolic, EndocrineDiabetes mellitus
- Registration Number
- ISRCTN70703138
- Lead Sponsor
- Justus Liebig University (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
1. Men or women aged 18 - 40 years at diagnosis
2. Established Type-1 Diabetes diagnosed up to three months ago
3. Consent to participate in a diabetes training programme
4. Informed consent before enrolment
1. History of neuropathy, nephropathy, and retinopathy of other than diabetes related origin
2. Negative C-peptide level at diagnosis
3. History of psychiatric disease or drug or alc ohol abuse
4. Treatment with oral antidiabetic medication
5. Subject unlikely to comply with the protocol (e.g. inability or unwillingness to participate adequate training or to complete diaries appropriately) or to understand the nature and the scope of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration